IB-110410395

N/A

Report date: 2025/03/25 10:58:20
NME

Base Information

Drug NameIB-110410395
Drug Alias NameID-110410395IB-110410395IB-11041
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCystic fibrosis transmembrane conductance regulator stimulantsPhosphodieterase 4 inhibitors
TargetsCystic fibrosis transmembrane conductance regulatorPhosphodieterase 4
Therapy Area/IndicationsDry Eye Syndromes
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesIldong Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesIldong Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsDry Eye Syndromes
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A